West Pharmaceutical Services10-Q: CEO changeJul 23, 2026

New executive Michel Lagarde's employment agreement dated May 31, 2026, signals CEO change.

Read at SEC EDGAR

What happened

The company filed an executive employment agreement for Michel Lagarde, indicating a change in top leadership.

Source

SEC EDGARJul 23, 2026

Quarterly report (Form 10-Q)

West Pharmaceutical Services 10-Q

Filing excerpt

Executive Employment Agreement between West Pharmaceutical Services, Inc. and Michel Lagarde, dated May 31, 2026 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed June 1, 2026).

sec.gov/Archives/edgar/data/105770/000010577026000099/wst-20260630.htmRead the full source

Other signals in this filing (8)

Internal control weaknessSuffered material cybersecurity attack in May 2026 leading to data exfiltration and operational disruption.Internal control weaknessJul 23, 2026
Cybersecurity incidentSuffered material cybersecurity attack in May 2026 with data exfiltration and system encryption.Cybersecurity incidentJul 23, 2026
Litigation materialFacing securities class action lawsuit alleging violations of the Securities Exchange Act.Litigation materialJul 23, 2026
CHRO changeCHRO Annette Favorite adopted a Rule 10b5-1 trading plan, signaling potential departure.CHRO changeJul 23, 2026
Cybersecurity investmentAnticipates significant and increasing costs to mitigate data security risks after major incident.Cybersecurity investmentJul 23, 2026
Supplier concentrationIdentifies dependency on single-source Japanese partner Daikyo for critical materials.Supplier concentrationJul 23, 2026
Supply chain disruptionHighlights dependence on single-source suppliers, including Japanese partner Daikyo.Supply chain disruptionJul 23, 2026
Inflation impactFacing margin pressure from rising costs of petroleum-based raw materials.Inflation impactJul 23, 2026

Extracted by Autobound

From the Signal API record

Signal: 10-Q: CEO change

What this signalsA new leader often reviews the tools the team uses.

Fiscal year end: 06/30
Filed: Jul 23, 2026

More 10-Q signals at other companies

SEC 10-QMillerKnoll, Inc.Jeffrey M. Stutz appointed Interim Chief Executive Officer.SEC 10-QSep 28, 2026
SEC 10-QCID HoldCo, Inc.Disclosed material weaknesses in financial reporting due to insufficient accounting staff and controls.SEC 10-QSep 25, 2026
SEC 10-QScholastic CorporationCore school channels decline with fewer book fairs and lower club participation.SEC 10-QSep 25, 2026

The full record

From the Signal API record

Details

CIK: 105770
Accession number: 0000105770-26-000099
Timeframe: Current quarter
Filing year: 2026
Fiscal year: 0
Why it matters: Full vendor review - highest priority
Signal category: Leadership

Extraction

Confidence: High
Relevance: 100%
Sentiment: Neutral
Detected: Jul 28, 2026
signal_type: sec-10q
signal_subtype: ceoChange

Use this data

Get every 10-Q signal for West Pharmaceutical Services and the companies you sell to, in the tools you already use.

Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at West Pharmaceutical Services this week?”
MCP setup guide
Send it to your own tools
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Signal API
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

linkedin_urlValue in the API
industriesValue in the API
employee_count_lowValue in the API
employee_count_highValue in the API
revenueValue in the API
descriptionValue in the API

Signal

signal_nameValue in the API
associationValue in the API

Start Free1,000 free creditsUse it in Claude via MCP

Show the full JSONThe record on this page and the API request

GET /v1/signals/fa45e5f3-87a4-4f36-8956-9a88294ac353 returns this record as JSON. POST /v1/companies/enrich returns every signal for westpharma.com.

{
  "signal_id": "fa45e5f3-87a4-4f36-8956-9a88294ac353",
  "signal_type": "sec-10q",
  "signal_subtype": "ceoChange",
  "detected_at": "2026-07-28T07:04:43.672+00:00",
  "company": {
    "name": "West Pharmaceutical Services",
    "domain": "westpharma.com"
  },
  "data": {
    "detail": "The company filed an executive employment agreement for Michel Lagarde, indicating a change in top leadership. A new CEO often re-evaluates strategy, budgets, and key vendor relationships within the first 6-12 months, creating significant opportunities for new solution providers.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "New executive Michel Lagarde's employment agreement dated May 31, 2026, signals CEO change.",
    "excerpts": "Executive Employment Agreement between West Pharmaceutical Services, Inc. and Michel Lagarde, dated May 31, 2026 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed June 1, 2026).",
    "relevance": 1,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/105770/000010577026000099/wst-20260630.htm",
    "filing_date": "2026-07-23",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Full vendor review - highest priority",
    "signal_category": "leadership"
  }
}

curl https://signals.autobound.ai/v1/signals/fa45e5f3-87a4-4f36-8956-9a88294ac353 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"westpharma.com","limit":20}'

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.